SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.45+0.1%Dec 5 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (652)8/27/2000 7:45:03 PM
From: gue  Read Replies (2) of 1475
 
Hey Rick,

I would say that it was a pretty balanced piece. It started off from the patients' point of view - all of those interviewed were very enthusiastic about the idea. Then they interviewed David Saks (Sachs?) and some other folks. The feature then discussed an English company called Immutron (?) who had introduced human genetic material into some pigs in the hopes of reducing the chance of rejection when the organs are transplanted [I hope I'm not blowing the explanation scientifically]. Then most of the discussion was devoted to the possibility of a pig virus infecting the general environment as a result of such transplantation with both viewpoints presented. I think that's about it.

gue

Edit: P.S. Apparently it was a rerun because they had a short update at the end discussing the recent successful pig cloning and other recent events.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News